These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of 131I-19-iodocholesterol scintigraphy and ultrasonography in the localization of a poorly vascularized phaeochromocytoma. Troncone L, Falappa PG, Cavallaro A, Netri G. Br J Radiol; 1981 Apr; 54(640):353-5. PubMed ID: 7225727 [No Abstract] [Full Text] [Related]
10. Localisation of adrenal adenoma with I 131-19 iodocholesterol. Dimopoulos C, Ikkos D. Br J Urol; 1977 Aug; 49(4):256. PubMed ID: 912247 [No Abstract] [Full Text] [Related]
11. 131I-6-iodocholesterol, an agent for imaging the adrenal gland. Jixiao M, Ruisen Z. Chin Med J (Engl); 1979 Apr; 92(4):237-46. PubMed ID: 108055 [No Abstract] [Full Text] [Related]
12. Imaging characterization of non-hypersecreting adrenal masses. Comparison between MR and radionuclide techniques. Maurea S, Caracò C, Klain M, Mainolfi C, Salvatore M. Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):188-97. PubMed ID: 15499292 [Abstract] [Full Text] [Related]
16. Adrenal scintigraphy in primary aldosteronism. Spironolactone as a cause of incorrect classification between adenoma and hyperplasia. Fischer M, Vetter W, Winterg B, Zidek W, Vetter H. Eur J Nucl Med; 1982 Feb; 7(5):222-4. PubMed ID: 7094925 [Abstract] [Full Text] [Related]